{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T01:05:18Z","timestamp":1783904718985,"version":"3.55.0"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_raon-2019-0047_s_005\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The impact of disease and treatment on the patient\u2019s overall well-being and functioning is a topic of growing interest in clinical research and practice. The aim of this study is to obtain reference data on quality of life of Croatian general population. Further, we aim to assess the impact of the disease and its primary systemic treatment on their health related quality of life (HrQoL) in multiple myeloma (MM) patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0047_s_006\">\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>Participants for the first part of the study were randomly selected from adult Croatian population. In the clinical part of the study MM patients were included as prospectively diagnosed within two years in two major Croatian haematological centres. The EORTC QLQ-C30 in both trials and QLQ-MY20 in MM patients only were applied for HrQoL assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0047_s_007\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Gender, age and place of residence have great impact on quality of life scores in Croatian population. The MM patients at the time of diagnosis have lower QLQ-C30 scores for global quality of life, functional and symptom scale scores, as well as single items. The type of disease followed by the choice of therapy options are important HrQoL determinants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_raon-2019-0047_s_008\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The norm values available now for Croatian population will help to interpret HrQoL for clinicians and aid in planning cancer care interventions. This study identified treatment effect consistent with those from other observational studies and provided new data on HrQoL across two different treatment choices for MM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/raon-2019-0047","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T18:20:38Z","timestamp":1569435638000},"page":"337-347","source":"Crossref","is-referenced-by-count":13,"title":["Health-related quality of life in Croatian general population and multiple myeloma patients assessed by the EORTC QLQ-C30 and EORTC QLQ-MY20 questionnaires"],"prefix":"10.2478","volume":"53","author":[{"given":"Sanja Ledinski","family":"Ficko","sequence":"first","affiliation":[{"name":"University of Applied Health Sciences, Department of Nursing , Zagreb , Croatia"},{"name":"University of Ljubljana, Interdisciplinary Doctoral Study of Biomedicine , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlatko","family":"Pejsa","sequence":"additional","affiliation":[{"name":"Clinical Hospital Dubrava, Institut of Hematology , Zagreb , Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Zadnik","sequence":"additional","affiliation":[{"name":"Institute of Oncology Ljubljana, Epidemiology and Cancer Registry , Ljubljana , Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2019,9,24]]},"reference":[{"key":"2026071215065427840_j_raon-2019-0047_ref_001","unstructured":"Croatian Institute of Public Health, Croatian National Cancer Registry. Cancer incidence in Croatia 2016. Bulletin No. 41. Zagreb: Croatian Institute of Public Health; 2019."},{"key":"2026071215065427840_j_raon-2019-0047_ref_002","doi-asserted-by":"crossref","unstructured":"King MT. The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Qual Life Res 1996; 5: 555-67. doi: 10.1007\/BF00439229","DOI":"10.1007\/BF00439229"},{"key":"2026071215065427840_j_raon-2019-0047_ref_003","doi-asserted-by":"crossref","unstructured":"Ford ME, Havstad SL, Kart CS. Assessing the reliability of the EORTC QLQ C-30 in a sample of older African and Caucasian adults. Qual Life Res 2001; 10: 533-41. doi: 10.1023\/A:1013003014340","DOI":"10.1023\/A:1013003014340"},{"key":"2026071215065427840_j_raon-2019-0047_ref_004","doi-asserted-by":"crossref","unstructured":"WHOQOL Group. Study protocol for the World Health Organization project to develop a quality of life assessment instrument Qual Life Res 1993; 2: 153-9. doi: 10.1007\/BF00435734","DOI":"10.1007\/BF00435734"},{"key":"2026071215065427840_j_raon-2019-0047_ref_005","doi-asserted-by":"crossref","unstructured":"Schwarz R, Hinz A. Reference Dana for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer 2001; 37: 1345-51. doi: 10.1016\/s0959-8049(00)00447-0","DOI":"10.1016\/S0959-8049(00)00447-0"},{"key":"2026071215065427840_j_raon-2019-0047_ref_006","doi-asserted-by":"crossref","unstructured":"Sherman AC, Simonton S, Latif U, Plante TG, Anaissie EJ. Changes in quality of life and psychosocial adjustment among MM patients treated with high dose malphalan and autologous stem cell transplantation. Biol Blood Marrow Transplant 2009; 15: 12-20. doi: 10.1016\/j.bbmt.2008.09.023","DOI":"10.1016\/j.bbmt.2008.09.023"},{"key":"2026071215065427840_j_raon-2019-0047_ref_007","doi-asserted-by":"crossref","unstructured":"Juul T, Petersen MA, Holzner B, Laurberg S, Christensen P, Gronvold M. Danish population- based reference data for the EORTC QLQ-C30: associations with gender, age and morbidity. Qual Life Res 2014; 23: 2183-93. doi: 10.1007\/s11136-014-0675-y","DOI":"10.1007\/s11136-014-0675-y"},{"key":"2026071215065427840_j_raon-2019-0047_ref_008","doi-asserted-by":"crossref","unstructured":"Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health- related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol 2011; 22: 2179-90. doi: 10.1093\/annonc\/mdq721","DOI":"10.1093\/annonc\/mdq721"},{"key":"2026071215065427840_j_raon-2019-0047_ref_009","doi-asserted-by":"crossref","unstructured":"Cocks K, King MT, Velikova G, Martyn St-James M, Fayers PM, Brown JM. Evidence-based guidelines for determination of sample size and interpretation of the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30 J Clin Oncol 2011; 29: 89-96. doi: 10.1200\/JCO.2010.28.0107","DOI":"10.1200\/JCO.2010.28.0107"},{"key":"2026071215065427840_j_raon-2019-0047_ref_010","doi-asserted-by":"crossref","unstructured":"Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76. doi: 10.1093\/jnci\/85.5.365","DOI":"10.1093\/jnci\/85.5.365"},{"key":"2026071215065427840_j_raon-2019-0047_ref_011","unstructured":"European Organization for Research and Treatment of Cancer. Questionnaires. [cited 2016 Jan 10]. Available at: https:\/\/qol.eortc.org\/questionnaire\/qlq-my20\/"},{"key":"2026071215065427840_j_raon-2019-0047_ref_012","unstructured":"European Organization for Research and Treatment of Cancer. Questionnaires (10.01.2016.) Available at: https:\/\/qol.eortc.org\/questionnaire\/eortc-qlq-c30\/"},{"key":"2026071215065427840_j_raon-2019-0047_ref_013","doi-asserted-by":"crossref","unstructured":"Lonneke V, van de Poll-Franse LV, Mols F, Gundy CM, Creutzberg CL, Nout RA, et al. Normative data for the EORTC QLQ-C30 and EORTC- sexuality items in the general Dutch population. Eur J Cancer 2011; 47: 667-75. doi: 10.1016\/j.ejca.2010.11.004","DOI":"10.1016\/j.ejca.2010.11.004"},{"key":"2026071215065427840_j_raon-2019-0047_ref_014","doi-asserted-by":"crossref","unstructured":"Michelson H, Bolund C, Nilsson B, Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30. Reference values from a large sample of the Swedish population. Acta Oncol 2009; 39: 477-84. doi: 10.1080\/028418600750013384","DOI":"10.1080\/028418600750013384"},{"key":"2026071215065427840_j_raon-2019-0047_ref_015","doi-asserted-by":"crossref","unstructured":"Velenik V, Secerov-Ermenc A, But-Hadzic J, Zadnik V. Health-related quality of life assessed by the EORTC QLQ-C30 questionnaire in the general Slovenian population. Radiol Oncol 2017; 51: 342-50. doi: 10.1515\/ raon-2017-0021","DOI":"10.1515\/raon-2017-0021"},{"key":"2026071215065427840_j_raon-2019-0047_ref_016","doi-asserted-by":"crossref","unstructured":"Slovacek L, Slovackova B, Blazek M, Jebavy L. Quality of life in patients with multiple myeloma and malignant lymphoma undergoing autologous progenitor stem cell transplantation: the effect of selected psychosocial and health aspects on quality of life: a retrospective analysis. Rep Pract Oncol Radiother 2007; 12: 101-8. doi: 10.1016\/S1507-1367(10)60046-6","DOI":"10.1016\/S1507-1367(10)60046-6"},{"key":"2026071215065427840_j_raon-2019-0047_ref_017","unstructured":"SurveyMonkey. Sample Size Calculator. Calculate your sample soize. [cited 2019 Jan 15]. Available at: https:\/\/www.surveymonkey.com\/mp\/sample-size-calculator"},{"key":"2026071215065427840_j_raon-2019-0047_ref_018","unstructured":"Fayers P, Aaronson NK, Bjordal K, Sullivan M. EORTC QLQ-C30 scoring manual Brussels: EORTC Publications; 1997."},{"key":"2026071215065427840_j_raon-2019-0047_ref_019","unstructured":"Tkalac Ver\u010di\u010d A, Sin\u010di\u0107 \u0106ori\u0107 D, Polo\u0161ki Voki\u0107 N Research methodology manual -How to design, implement and describe scientific and professional research. Zagreb: M.E.P. d.o.o; 2012."},{"key":"2026071215065427840_j_raon-2019-0047_ref_020","unstructured":"Petz B, Kolesari\u0107 V, Ivanec D. Petzova statistics [Croatian]. Zagreb: Naklada Slap; 2012."},{"key":"2026071215065427840_j_raon-2019-0047_ref_021","unstructured":"\u0160o\u0161i\u0107 I. Applied statistics 2 [Croatian]. Updated edition. Zagreb: \u0160kolska knjiga; Zagreb 2006."},{"key":"2026071215065427840_j_raon-2019-0047_ref_022","doi-asserted-by":"crossref","unstructured":"Nielsen LK, Abildgaard N, Jarden M, Wirenfeld Klausen T. Methodological aspects of health-related quality of life and analysis in patients with multiple myeloma. Br J Haematol 2019; 185: 1-14. doi: 10.1111\/bjh.15759","DOI":"10.1111\/bjh.15759"},{"key":"2026071215065427840_j_raon-2019-0047_ref_023","doi-asserted-by":"crossref","unstructured":"Giesinger JM, Kieffer JM, Fayers PM, Groenvold M, Petersen MA, Scott NW, et al. Replication and validation of higher order models demonstrated that a summary score for the EORTC QLQ-C30 is robust. J Clin Epidemiol 2016; 69: 79-88. doi: 10.1016\/j.jclinepi.2015.08.007","DOI":"10.1016\/j.jclinepi.2015.08.007"},{"key":"2026071215065427840_j_raon-2019-0047_ref_024","unstructured":"Bejakovi\u0107 P, Kaliterna Lipov\u010dan LJ. Quality of life in Croatia: key findings from national research. Dublin: European Foundation for the Improvement of Living and Working Conditions; 2007."},{"key":"2026071215065427840_j_raon-2019-0047_ref_025","doi-asserted-by":"crossref","unstructured":"Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S. Health related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer Core Quality \u2013of-Life Questionnaire: The QLQ=C30 (+3). J Clin Oncol 1998; 16: 1188-96. doi: 10.1200\/JCO.1998.16.3.1188","DOI":"10.1200\/JCO.1998.16.3.1188"},{"key":"2026071215065427840_j_raon-2019-0047_ref_026","unstructured":"Ministry of Regional Development and European Union Funds. Development index. [cited 2018 Jun 21]. Available at: https:\/\/razvoj.gov.hr\/o-ministarstvu\/regionalni-razvoj\/indeks-razvijenosti\/112"},{"key":"2026071215065427840_j_raon-2019-0047_ref_027","unstructured":"Government of Republic of Croatia. Act on Regional Development of the Republic of Croatia 147\/14, 123\/17. NN. 132\/2017. [cited 2018 Jun 21]. Available at: https:\/\/www.zakon.hr\/z\/239\/Zakon-o-regionalnom-razvojuRepublike-Hrvatske"},{"key":"2026071215065427840_j_raon-2019-0047_ref_028","doi-asserted-by":"crossref","unstructured":"Delforge M, Minuk L, Eisenmann JC, Arnulf B, Canepa L, Fragasso A, et al. Health-related quality of life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide. Haematologica 2015; 100: 826-33. doi: 10.3324\/haematol.2014.120121","DOI":"10.3324\/haematol.2014.120121"},{"key":"2026071215065427840_j_raon-2019-0047_ref_029","doi-asserted-by":"crossref","unstructured":"Despiegel N, Touboul C, Flinois A, Saba G, Suzan F, Gonzales-McQuire S. Health-related quality of life of patients with multiple myeloma treated in routine clinical practice in France. Clin Lymphoma Myeloma Leuk 2018; 19: 13-28. doi: 10.1016\/j.clml.2018.08.01","DOI":"10.1016\/j.clml.2018.08.019"},{"key":"2026071215065427840_j_raon-2019-0047_ref_030","doi-asserted-by":"crossref","unstructured":"Uyl-de Groot CA, Buijt I, Gloudemans IJM, Ossenkoppele GJ, Van den Berg HP, Huijgens PC. Health related quality of life in patients with multiple myeloma undergoing a double transplantation. Eur J Haematol 2005; 74: 136-43. doi: 10.1111\/j.1600-0609.2004.00346.x","DOI":"10.1111\/j.1600-0609.2004.00346.x"},{"key":"2026071215065427840_j_raon-2019-0047_ref_031","doi-asserted-by":"crossref","unstructured":"Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality of life scores. J Clin Oncol 1998; 16: 139-44. doi: 10.1200\/JCO.1998.16.1.139","DOI":"10.1200\/JCO.1998.16.1.139"},{"key":"2026071215065427840_j_raon-2019-0047_ref_032","doi-asserted-by":"crossref","unstructured":"Gjural S, Conroy T, Fleissner C, Sezer O, King PM, Avery KN, et al. Assessing quality of life in patients with colorectal cancer: An update of the EORTC quality of life questionnaire. Eur J Cancer 2007; 43: 1564-73. doi: 10.1016\/j. ejca.2007.04.005","DOI":"10.1016\/j.ejca.2007.04.005"},{"key":"2026071215065427840_j_raon-2019-0047_ref_033","doi-asserted-by":"crossref","unstructured":"Lange MM, Marijnen CAM, Maas CP, Putter H, Rutten HJ, Stiggelbout AM, et al. Risk factors for sexual dysfunction after rectal cancer treatment. Eur J Cancer 2009; 45: 1578-88. doi: 10.1016\/j.ejca.2008.12.014","DOI":"10.1016\/j.ejca.2008.12.014"},{"key":"2026071215065427840_j_raon-2019-0047_ref_034","doi-asserted-by":"crossref","unstructured":"Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. Health and Quality of Life Outcomes. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009; 18: 7-25. doi:10.1186\/1477-7525-7-25","DOI":"10.1186\/1477-7525-7-25"}],"container-title":["Radiology and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/raon\/53\/3\/article-p337.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/raon-2019-0047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:10:07Z","timestamp":1783901407000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/raon-2019-0047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,24]]},"published-print":{"date-parts":[[2019,9,24]]}},"alternative-id":["10.2478\/raon-2019-0047"],"URL":"https:\/\/doi.org\/10.2478\/raon-2019-0047","relation":{},"ISSN":["1581-3207"],"issn-type":[{"value":"1581-3207","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,1]]}}}